BevCanna Enterprises



HempFusion Announces New Chief Financial Officer

HempFusion Launches Probulin Probiotics in Ireland’s Top Retailer

HempFusion Launches Private Label Business Division, Awarded 10 SKU Private Label Deal with Leading National Retailer

HempFusion CBD and Probulin Probiotics Partner with Two-Time Olympic Gold Medalist and Five-Time World Champion, Kaillie Humphries

HempFusion Signs Definitive Agreement to Acquire Leading CBD Brand Sagely Naturals

HempFusion Commends the Proposed Hemp Access and Consumer Safety Act

HempFusion Reports Q1, 2021 Financial Results

HempFusion Wellness Inc. Announces 2021 AGM Voting Results

HempFusion Signs Definitive Agreement to Acquire Pioneering CBD Brand Apothecanna

HempFusion Accelerates International Sales with United Arab Emirates Reopening

HempFusion Wellness Inc. To Report First Quarter 2021 Earnings and Host Conference Call on May 17, 2021

HempFusion Comments on Recent Trading Activity, All Projects, Incl. Five Channel Strategy, in Motion and Strong Cash-On-Hand

HempFusion's Products Enter Asia Through Alibaba Group’s Tmall Global

HempFusion Provides Operational Update

HempFusion Wellness Inc. Reports Filing of Fiscal 2020 Results

HempFusion Completes Inflammatory Markers Pilot Trial, Releases White Paper

HempFusion Wellness Announces Toxicology Results from Validcare’s Clinical Study on CBD Liver Safety

HempFusion Wellness Enters China with Probulin Probiotics Through Alibaba Group’s Tmall Global, Reaching More Than 750 Million Potential New Consumers

HempFusion Is the Top Performing Topical CBD Brand at Major Food-Drug Mass Retailer

HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency

HempFusion Wellness Announces Broadening of Share Liquidity With DTC Full-Service Eligibility

HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York